Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cole Hair Transplant Group is a specialized medical practice and research organization focused on advanced hair restoration techniques. Founded by Dr. John P. Cole, the group is renowned for developing the Cole Isolation Technique (CIT), a refined version of Follicular Unit Extraction (FUE) that minimizes trauma and maximizes graft survival. In addition to surgical procedures, the company integrates regenerative medicine, including Platelet Rich Plasma (PRP) and stem cell-based therapies, to enhance hair density and healing. The group also operates a division for surgical instrumentation, providing specialized tools to hair transplant surgeons worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cole Hair Transplant Group.